Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Opus Genetics, Inc.OCUP · Entity 5892 | Chief Business Officer | January 10, 2024 | January 12, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Opus Genetics, Inc.
Report date January 10, 2024 · Filed January 12, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 90,714 |
Reported balance
After 2024-01-10 transaction · row 1
1 source rowRow 1 · 2024-01-10 · Tax withholding · Disposed 1,282 · Balance 90,714 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 10, 2024 Filed Jan 12, 2024 21:17 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | Tax withholdingCommon Stock | 1,282 | $3.27 | $4,185.73 |
DisclosureSEC source: 0001140361-24-002127 · form4.xml · nonDerivative · entry 1 Patel Ronil A. · CIK 0001974660 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,714 Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:30 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantEmployee Stock Option (right to buy) · Derivative | 74,538 | $0.00 Strike: $2.99 | $0.00 |
DisclosureSEC source: 0001140361-23-056374 · form4.xml · derivative · entry 2 Patel Ronil A. · CIK 0001974660 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,538 Underlying: Common Stock · 74,538 shares Expires 2033-11-30 F2 · derivative.exercise_date: The option will vest with respect to 25% on the six month anniversary of the grant date, with the remaining shares vesting in equal installments every six months thereafter over the two years following the grant date, subject to continuing service. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:30 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantCommon Stock | 49,692 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-056374 · form4.xml · nonDerivative · entry 1 Patel Ronil A. · CIK 0001974660 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,996 F1 · shares: Represents a grant of restricted stock units which vest with respect to 25% on the six month anniversary of the grant date, with the remaining shares vesting in equal installments every six months thereafter over the two years following the grant date, subject to continuing service. Read SEC document |
| April 24, 2023 Filed Apr 27, 2023 01:25 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.35 | $0.00 |
DisclosureSEC source: 0001140361-23-020662 · form4.xml · derivative · entry 2 Patel Ronil A. · CIK 0001974660 · SVP, Operations & Bus. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-04-23 F2 · derivative.exercise_date: The option will vest with respect to 7,500 shares on April 24, 2024, with the balance vesting quarterly in twelve equal installments thereafter. Read SEC document |
| April 24, 2023 Filed Apr 27, 2023 01:25 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-020662 · form4.xml · nonDerivative · entry 1 Patel Ronil A. · CIK 0001974660 · SVP, Operations & Bus. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,304 F1 · shares: Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of April 24, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.